Delivery Order SPE2DU25D4211-SPE2DU26FC098
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,667.42 to AmerisourceBergen Drug Corp on January 12, 2026, under a competitively awarded, non-set-aside contract. This delivery order represents a task order issued against the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency has awarded a $42,594.80 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply under a Firm Fixed Price contract. This delivery order, issued on October 28, 2025, represents a child order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation, indicating competitive award among...
- The Defense Logistics Agency awarded a delivery order valued at $1,724.38 to AmerisourceBergen Drug Corp on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $39,363.10 to AmerisourceBergen Drug Corp for pharmaceutical products and services under a firm fixed price contract structure. This non-competitive delivery order, issued on December 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $28,899.74 to AmerisourceBergen Drug Corp, a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 23, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,579.10 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a non-set-aside award, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,376.55 to AmerisourceBergen Drug Corp, the pharmaceutical distribution division of parent company Cencora, Inc., on January 29, 2026, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, was competitively awarded through the DLA's Medical Supply Chain and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $44,723.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 12, 2025, with an ultimate completion date of the same date. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 million comprehensive pharmaceutical support vehicle running through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,116.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, with completion expected by January 14, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The delivery order is to be performed at the awardee's corporate office location in...
- SPE2DU25D4211Indefinite Delivery Contract
- SPE2DU25D4211-SPE2DU26FC098Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,840.52 to AmerisourceBergen Drug Corp for pharmaceutical products and supplies. This non-set-aside delivery order, issued on February 2, 2026, with an ultimate completion date of February 2, 2026, represents a task order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing comprehensive medical supply solutions to federal agencies. This delivery order falls under the broader DLA Troop Support Medical IDC valued at $999,999,999.00 through December 2026, which serves as a critical global pharmaceutical supply vehicle for military healthcare programs. AmerisourceBergen's contract portfolio with the DLA encompasses an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal contracting demonstrates consistent capability to compete on a full and open basis and efficiently fulfill government requirements for essential pharmaceutical and medical commodities supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 2/1/26 |